Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
President Donald Trump’s approval rating decreased one point from last week in the latest poll, as persistent economic concerns and declining confidence in his immigration policies weigh on Americans’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results